Telemonitoring could radically change individualised heart failure treatment

Professor Cleland (University Hull, UK) reinforced the ‘hard messages’ around telehealth monitoring of patients, as reported in this conference press release: “rapid technical evolution has run far ahead of any service evolution, and conventional clinical trials are likely to underestimate the benefits of these new telehealth systems once integrated into an efficient service. Future clinical trials, he said, should ensure service integration and define the ‘control’ intervention: “If service integration is poor or insufficient resources are invested in the control group, then even an effective technology will fail.”